UNSPSC 41142007: Immunoreactive insulin test system

In this classification, Immunoreactive insulin test system connotes a device used to measure Immunoreactive insulin levels. US FDA regulates Immunoreactive insulin test system under 21 CFR 862.1405 and under FDA product code CFP.

UNSPSC 41142007 Immunoreactive insulin test system (Commodity) describes laboratory reagents and reference materials used in forensic drug analysis, toxicology screening, and pathogen detection — a narrower scope than the abstract code name suggests. State and local governments procure these materials through direct competitive bidding and sole-source awards to support crime laboratories, public health agencies, and forensic operations. Issuing bodies include state law enforcement and health departments, county forensic labs, and state purchasing offices coordinating multi-jurisdictional master contracts. Work spans direct ELISA testing kits for substance analysis (cannabinoids, opiates, PCP, amphetamines, benzodiazepines, cocaine, and other controlled substances), certified reference materials with ISO/IEC 17025 accreditation and purity standards exceeding 97%, DNA screening kits for qualitative and multiplex PCR applications, and West Nile Virus and Dengue test kits for mosquito surveillance. Contracts typically run 12 months with extension options and are governed by state procurement codes emphasizing best value evaluation, vendor performance ratings, and compliance with federal funding regulations where applicable.

Recent activity concentrates in Texas and Florida, with secondary presence in Illinois. The Texas Department of Public Safety Crime Lab Division issued IFB 405-26R0008445A (posted July 9, 2026; due July 23, 2026) for 12 line items of Direct ELISA testing kits covering substance analysis, with estimated quantities of 3 to 30 units per item and anticipated award July 24, 2026. The Texas Health and Human Services Commission (for the Department of State Health Services) posted IFB HHS0016902v2 (due January 29, 2026) for QIAxcel and QIAamp DNA screening kits totaling seven line items with historical spend between $25,050 and $30,000 for the prior fiscal year. Pinellas County, Florida, in partnership with the Florida Department of Law Enforcement, solicited certified drug reference standards through ITQ 26-0305-ITQ (posted April 23, 2026; due April 23, 2026) encompassing 131 line items with approximately $49,034 in federal Coverdell Act funding designated for equipment and supplies; Pinellas County certified small businesses receive preference with early submission priority. Illinois Department of Financial and Professional Regulation's Centralized Maintenance Services established a joint purchase master contract for mosquito testing equipment (RAMP System test kits) through sole-source procurement to ADAPCO, LLC (notice of intent posted May 4, 2026).